A new technique of 99mTc-ciprofloxacin kit preparation

I. Kleisner; P. Komarek; I. Komarkova; M. Konopkova

doi:10.1055/s-0038-1625292

Nuklearmedizin - NuclearMedicine, Inhaltsverzeichnis

Nuklearmedizin 2002; 41(05): 224-229
DOI: 10.1055/s-0038-1625292

Editorial

Schattauer GmbH

A new technique of ^99mTc-ciprofloxacin kit preparation

Neue Methode der Zubereitung des ^99mTc-Ciprofloxacin-Kits

I. Kleisner

¹Department of Nuclear Medicine, Kralovske Vinohrady University Hospital

,

P. Komarek

²Pharmaceutical Technology and Drug Control, Postgraduate Medical School

,

I. Komarkova

³Radiopharmacy, State Institute for Drug Control

,

M. Konopkova

⁴Nuclear Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

› Institutsangaben

Abstract

Summary

Aim: Development of a simple and reproducible method for preparing a ciprofloxacin kit using a redox polymer, which would meet the requirements for an easy and reliable technique of labelling with ^99mTc and diagnostic efficiency in scintigraphic imaging of infections. Material and methods: To prepare the kit, an insoluble redox polymer containing an end α(β)-alanine-N, N’-diacetate group anchored to the dextran matrix was used. The redox polymer synthesised by the authors was incubated at room temperature (10 h) with a solution of ciprofloxacin (1%) in a suspension (5%). The mixture was then filtered and dispensed into sterile vials (0.2 ml each). The kit was labelled with ^99mTc for 10 min at room temperature. The radiochemical purity of the ciprofloxacin-^99mTc complex was determined by ITLC and paper chromatography in relation to the following factors: pH, total content of ciprofloxacin, volume of sodium ^99mTc-pertechnetate. Ciprofloxacin biodistribution was evaluated in Wistar rats with Staphylococcus aureus infection in the left inguinal region 24 h after abscess induction. Accumulation of ^99mTc activity was determined both using external gamma camera imaging and counting dissected tissues 1 h after administration. Results: Radiochemical purity is >95% for kit-labelling (pH 3.3-3.7). With pH 3.45, labelled ciprofloxacin shows the highest stability and radiochemical purity. The ^99mTc-ciprofloxacin complex is stable for at least 8 h. In experimentally induced inflammation, the amount of accumulated ^99mTc-ciprofloxacin activity is five times higher than in controls. Conclusion: The developed method of ^99mTc-ciprofloxacin kit preparation employs a redox polymer in a new procedure, which enables the preparation of a stable kit with a high ^99mTc-labelling efficiency. The labelled kit is suitable for scintigraphic imaging of infection.

Zusammenfassung

Ziel: Entwicklung einer einfachen und reproduzierbaren Methode basierend auf einem Redoxpolymer zur verlässlichen Markierung und präzisen Szintigraphie von Infektionsherden. Methoden: Zur Herstellung des Kits wurde ein unlösliches Redoxpolymer mit endständiger α(β)-Alanin-N, N’-diazetatgruppe, gebunden an eine Dextranmatrix, benutzt. Das von den Autoren synthetisierte Redoxpolymer wurde in 5%iger Suspension 10 h bei Zimmertemperatur mit einer Ciprofloxacinlösung (1%) inkubiert. Danach wurde die filtrierte Mixtur in sterile Reagenzgläser gefüllt (je 0,2 ml). Die Markierung des Kits mit ^99mTc erfolgte bei Zimmertemperatur (Dauer: 10 min). Die radio-chemische Reinheit von ^99mTc-Ciprofloxacin wurde durch ITLC und Papierchromatographie getestet. Berücksichtigt wurden folgende Faktoren: pH, Ciprofloxacin-Gesamtgehalt, Natrium-^99mTc-pertechnetat-Volumen. Die Ciprofloxacin-Biodistribution wurde bei Wistar-Ratten mit abszessförmiger Staphylococcus-aureus-Infektion der linken Inguinalregion nach 24 h untersucht. Die Anreicherung der ^99mTc-Aktivität wurde mittels Gamma-kameraszintigraphie beurteilt. Ergebnisse: Radio-chemische Reinheit der Kit-Markierung >95% (pH 3,3-3,7). Bei pH 3,45 besitzt das markierte Ciprofloxacin die höchste Stabilität und radiochemische Reinheit. Der ^99mTc-Ciprofloxacin-Komplex bleibt mindestens 8 h stabil. Die Anreicherung von ^99mTcCiprofloxacin in Gewebe mit experimentell induzierter Entzündung ist fünfmal höher als im Kontrollgewebe. Schlussfolgerung: Die vorgestellte Methode der ^99mTcCiprofloxacin-Kit-Herstellung basierend auf einem neuartigen Redoxpolymer führt zu stabilen Kits mit hoher Markierung, die zur szintigraphischen Darstellung von Infektionen geeignet sind.

Keywords

Redox polymer - ^99mTc-ciprofloxacin kit - biodistribution - infection imaging

Schlüsselwörter

Redoxpolymer - ^99mTc-Ciprofloxacin-Kit - Biodistribution - Infektionsszintigraphie

Volltext

Referenzen

References
1 Britton KE, Vinjamuri S, Hall AV. et al. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med 1997; 24: 553-6.
2 Britton KE, Wareham DW, Das SS. Concerns about ^99mTc-labelled ciprofloxacin for infection detection. Eur J Nucl Med 2001; 28: 779-81.
3 Buscombe JR, Miller RF, Lui D. et al. Combined Gallium-67-citrate and ^99mTc-human immunoglobulin imaging in human immuno-deficiency virus-positive patients with fever of unknown origin. Nucl Med Commun 1991; 12: 583-92.
4 Ciprinol inj. – Summary of product characteristics, Krka, Slovenia (2000).
5 De Winter F, van de Wiele Ch, Dumont F. et al. Biodistribution and dosimetry of ^99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection. Eur J Nucl Med 2001; 28: 570-4.
6 Kleisner I, Komarek P, Komarkova I. et al. The use of redox polymers in labelling procedures of proteins and peptides with ^99mTc. I. Properties of redox polymers and technique of labelling. Nucl Med Rev 2000; 3: 65-8.
7 Komarek P, Kleisner I, Komarkova I. et al. The use of redox polymers in labelling procedures of proteins and peptides with ^99mTc. II. Technique of preparations of kits for protein labelling by ^99mTc and its effect on stability and radio-chemical purity. Nucl Med Rev 2000; 3: 69-72.
8 McAfee JG, Gagne G, Subramanian G. et al. The localisation of indium-111-leukocytes, gallium-67, polyclonal IgG and other radioactive agents in acute focal inflammatory lesions. J Nucl Med 1991; 32: 2126-31.
9 Martins PA, Faintuch BL, Pereira NPS. et al. Optimization of labeling ciprofloxacin with ^99mTc and biodistribution in normal and infected rats. J Nucl Med 2001; 42: 264P.
10 Pirmettis I, Limouris GS, Papadopoulos M. et al. Potential infection imaging agents: preparation and biodistribution of ^99mTc-norfloxacin and ^99mTc-ciprofloxacin. Eur J Nucl Med 1999; 26: 1108.
11 Seabold JE, Forstrom LA, Schauwecker DS. et al. Procedure guideline for indium-111-leukocyte scintigraphy for suspected infection/ inflammation. J Nucl Med 1997; 38: 997-1001.
12 Seabold JE, Palestro CJ, Brown ML. et al. Procedure guideline for gallium scintigraphy in inflammation. J Nucl Med 1997; 38: 994-7.
13 Schrijver MD, Streule K, Senekowitsch R. et al. Scintigraphy of inflammation with nanometer-sized colloidal tracers. Nucl Med Commun 1987; 8: 895-908.
14 Spinelli F, Milella M, Sara R. et al. The value of ^99mTc-labelled human immunoglobulin scanning in the evaluation of Crohn´s disease. Eur J Nucl Med 1990; 16: 436.
15 Staab EV, McCartney H. Role of ⁶⁷Gallium in inflammatory disease. Semin Nucl Med 1978; 8: 219-34.
16 Van der Laken CJ, Boerman OC, Oyen JG. et al. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction. Eur J Nucl Med 1998; 25: 535-46.
17 Vinjamuri S, Hall AV. Comparison of ^99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347: 233.